Pediatric and Geriatric Pharmacology Practice Questions

Q: Which pharmacokinetic change commonly occurs in geriatric patients?

Renal clearance. **Explanation:** The physiological process of aging leads to significant alterations in pharmacokinetics, primarily affecting drug elimination. **1. Why Renal Clearance is the Correct Answer:** The most predictable and clinically significant pharmacokinetic change in geriatric patients is a **decrease in renal clearance**. This occurs due to a progressive decline in the Glomerular Filtration Rate (GFR), reduced renal blood flow, and a decrease in the number of functional nephrons. Even if serum creatinine appears normal (due to reduced muscle mass in the elderly), the actual clearance is often significantly reduced, necessitating dose adjustments for drugs like Digoxin, Aminoglycosides, and Lithium. **2. Analysis of Incorrect Options:** * **A. Gastric Absorption:** While there is a decrease in gastric acid secretion and mucosal surface area, the **passive absorption** of most drugs remains largely unaffected in the elderly. * **B. Liver Metabolism:** Although liver mass and blood flow decrease, Phase II reactions (conjugation) remain relatively preserved. While Phase I (oxidation) may slow down, the change is less consistent and predictable than the decline in renal function. * **D. Hypersensitivity:** This is a **pharmacodynamic** or immunological change, not a pharmacokinetic one. While elderly patients may show increased sensitivity to certain drugs (e.g., CNS depressants), it is not a change in how the body handles the drug's concentration. **High-Yield Clinical Pearls for NEET-PG:** * **Cockcroft-Gault Formula:** Always use this to estimate CrCl in the elderly, as serum creatinine alone is misleading. * **Body Composition:** Geriatrics show **increased body fat** (increasing the half-life of lipid-soluble drugs like Diazepam) and **decreased total body water/albumin** (increasing the free fraction of water-soluble or highly protein-bound drugs). * **Rule of Thumb:** "Start low and go slow."

Q: Gray baby syndrome is caused by which of the following drugs?

Chloramphenicol. **Explanation:** **Gray Baby Syndrome** is a serious and potentially fatal adverse reaction associated with the administration of **Chloramphenicol** in neonates (especially premature infants). **Why Chloramphenicol is the correct answer:** The syndrome occurs due to the physiological immaturity of the neonatal liver and kidneys. There are two primary mechanisms: 1. **Deficiency of Glucuronyl Transferase:** Neonates lack sufficient levels of this enzyme, which is required to conjugate chloramphenicol into its inactive form. 2. **Reduced Renal Excretion:** Immature kidneys cannot effectively excrete the unconjugated drug. This leads to toxic accumulation of the drug, causing mitochondrial injury. Clinical features include abdominal distension, vomiting, progressive cyanosis (giving the skin a characteristic **ash-gray color**), hypothermia, and cardiovascular collapse. **Why other options are incorrect:** * **Chlorpromazine:** An antipsychotic that can cause extrapyramidal symptoms or neonatal withdrawal if used during pregnancy, but not Gray Baby Syndrome. * **Phenytoin:** An antiepileptic known for **Fetal Hydantoin Syndrome** (cleft lip/palate, microcephaly) if taken during pregnancy, and gingival hyperplasia in children. * **Gentamycin:** An aminoglycoside primarily associated with **ototoxicity and nephrotoxicity** in all age groups. **High-Yield Clinical Pearls for NEET-PG:** * **Treatment:** Immediate discontinuation of the drug; exchange transfusion or charcoal hemoperfusion may be required. * **Other Chloramphenicol Side Effects:** Dose-dependent bone marrow suppression and idiosyncratic **Aplastic Anemia** (most serious). * **Drug of Choice:** Chloramphenicol remains a backup for Typhoid fever and H. influenzae meningitis in specific settings, but its use is strictly limited in neonates.

Q: Most common cause of Mobius syndrome is the use of which of the following drugs in pregnancy?

Misoprostol. **Explanation:** **1. Why Misoprostol is the Correct Answer:** Misoprostol is a synthetic prostaglandin E1 (PGE1) analog frequently used off-label as an abortifacient. When used in the first trimester for failed medical abortion, it can cause **vascular disruption** in the developing fetus. The leading theory is that misoprostol-induced uterine contractions lead to transient uterine ischemia, affecting the development of the cranial nerve nuclei (specifically the 6th and 7th nerves). This results in **Mobius Syndrome**, characterized by congenital facial paralysis and impaired ocular abduction (mask-like facies). **2. Why Other Options are Incorrect:** * **Thalidomide:** Classically associated with **Phocomelia** (seal-like limbs), amelia, and internal organ defects. While it can cause ear and eye abnormalities, it is not the primary cause of Mobius syndrome. * **Methotrexate:** A folic acid antagonist that causes **Fetal Hydantoin-like syndrome** or "Methotrexate embryopathy," characterized by skull defects (craniosynostosis), limb malformations, and growth retardation. * **Dinoprostone:** A PGE2 analog used for cervical ripening at term. It is not typically associated with first-trimester teratogenicity or Mobius syndrome, as it is not commonly used for early medical abortions. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mobius Syndrome Triad:** Facial nerve palsy (CN VII), Abducens nerve palsy (CN VI), and often limb defects (e.g., clubfoot). * **Misoprostol Teratogenicity:** Apart from Mobius syndrome, it is also linked to **Terminal Transverse Limb Defects**. * **Safe Alternatives:** For labor induction, Dinoprostone is preferred; for postpartum hemorrhage (PPH), Misoprostol is a key drug. * **Other Vascular Disruptors:** Cocaine and Ergotamine are also associated with vascular-mediated fetal defects.

Question 1

What is the effect of indomethacin on the ductus arteriosus?

Accepted Answer

Closure of the ductus in premature neonates

Answer

Patent ductus arteriosus

Answer

Closure of the ductus in term and premature neonates

Answer

Closure of the ductus in older children

Question 2

Which pharmacokinetic change commonly occurs in geriatric patients?

Accepted Answer

Renal clearance

Answer

Gastric absorption

Answer

Liver metabolism

Answer

Hypersensitivity

Question 3

Gray baby syndrome is caused by which of the following drugs?

Accepted Answer

Chloramphenicol

Answer

Chlorpromazine

Answer

Phenytoin

Answer

Gentamycin

Question 4

What is the mechanism by which phenobarbital and metalloporphyrin act respectively to reduce bilirubin levels in neonatal jaundice?

Accepted Answer

Induce bilirubin conjugation by UDP Glucuronyltransferase and competitive inhibition of hemeoxygenase

Answer

Enhance secretion of conjugated bilirubin and induce bilirubin conjugation by UDP Glucuronyltransferase

Answer

Induce bilirubin conjugation by UDP Glucuronyltransferase and enhance secretion of conjugated bilirubin

Answer

Competitive inhibition of hemeoxygenase and enhance secretion of conjugated bilirubin

Question 5

Most common cause of Mobius syndrome is the use of which of the following drugs in pregnancy?

Accepted Answer

Misoprostol

Answer

Thalidomide

Answer

Methotrexate

Answer

Dinoprostone

Pediatric and Geriatric Pharmacology — MCQs

Pediatric and Geriatric Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?